Related Experiment Video
Updated: Feb 24, 2026

12:24
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
6.2K
[Hepatitis C: epidemiology, management and treatment]
1Service d'Hépatologie, Hôpital Saint-Antoine, 75771 Paris.
Bulletin De L'Academie Nationale De Medecine
|August 24, 2005
Summary
Hepatitis C virus (HCV) infection is a significant public health issue. This review updates on HCV epidemiology, diagnosis, and management, emphasizing individualized treatment strategies for optimal outcomes.
Area of Science:
- Hepatology
- Virology
- Public Health
Context:
- Hepatitis C virus (HCV) poses a major public health challenge, leading to chronic liver disease.
- An estimated 400,000 individuals in France are currently infected with HCV.
- Approximately 4000 new cases of HCV infection occur annually in France.
Purpose:
- To provide an updated review of Hepatitis C virus (HCV) epidemiology.
- To outline current diagnostic approaches for HCV infection.
- To detail management and therapeutic strategies for HCV.
Summary:
- Testing for HCV RNA is crucial for all suspected chronic HCV infections, as seropositivity without viremia is common.
- HCV genotype determination is essential before treatment to optimize therapy duration and predict response.
- Individualized treatment decisions for HCV should consider liver disease severity, potential adverse effects, treatment response likelihood, and comorbidities.
Impact:
- Peginterferon-ribavirin combination therapy offers sustained viral clearance in up to 85% of patients with HCV genotypes 2 and 3.
- This combination achieves sustained viral clearance in up to 50% of patients with HCV genotype 1 infection.
- Updated management guidelines aim to improve patient outcomes and reduce the burden of chronic liver disease caused by HCV.
Related Concept Videos
Endocarditis III: Medical Management
280
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
280
Esophageal Varices-II: Clinical Features and Management
658
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
658
Retrovirus Life Cycles
49.9K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.9K
Pleural Effusion II: Symptoms and Management
873
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
873
Pulmonary Tuberculosis V
669
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
669
Cystic Fibrosis: Management
573
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
573

